The Pune-based software services company said it is optimistic about newer technologies like blockchain and machine learning.
Steel stocks slumped more than 15 percent in the last three months as prices declined and input costs rose.
Investors and analysts are concerned about a Sun Pharma secret.
While most brokerages said most of the queries have been answered, three concerns still remain.
Shares of Sun Pharma tumbled as much as 13.21 percent, the most in a year and a half on Monday.
Tata Steel plans to raise its India capacity to 30 million tonnes per annum by 2025 from 13 MTPA.
Why capital goods makers are showing signs of rebound...
Emerging markets will be again in favour as the recent rout narrowed gap with developed economies, global brokerages say.
Dewan Housing sold loans worth Rs 7,400 crore to eight banks and repaid Rs 14,000 crore of debt since Sept. 24.
The ruling comes at a time when the U.S. sales of DRL failed to meet brokerages estimates for the quarter ended September.
Earnings of 34 of the Nifty 50 firms either surpassed or were in line with consensus estimates of analysts tracked by Bloomberg.
Glenmark’s CMD Glenn Saldanha said markets are “overly concerned on debt in his balance sheet”.
Siemens India reported its best quarterly performance in six financial years on higher revenue across all segments.
The company posted a net loss of Rs 219 crore against Rs 912 crore profit reported in the year-ago period.
Deloitte Haskins & Sells highlights receivables and processing fee paid for an undisclosed loan by 8K Miles Software.
Of the 44 companies that have reported Q2 results, 45 percent met the consensus earnings per share estimate.
Dr. Reddy’s received eight observations, five of them a repeat of 2017 and warning letter, from the U.S. FDA at its Duvvada plant.
Analsyts cut FY19 earnings per share estimates for Cipla in the range of 10-25 percent.
Here’s why the U.S. FDA’s Form 483 to Dr. Reddy’s Duvvada plant is relevant.
Of the 10 IPOs in FY19, shares of only three companies are trading above their issue price and two are above their listing price.
The second quarter earnings season has been mixed so far with lack of a clear trend either on strong or weak side.